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•  National estimates of inpatient 
mortality in the US are available 
through the National Inpatient 
Sample (NIS) from the Health Cost 
and Utilization Project (HCUP).
•  A discharge-weighted national 
estimate of 605 TIPS procedures 
performed in BCS patients NIS from 
2003 – 2012 using International 
Classification of Diseases-9 (ICD-
9) procedural code 39.1 and 
diagnostic code 453.1.
•  Multivariate analysis, bivariate 
logistic regression, analysis of 
variance (ANOVA), post-hoc Tukey 
tests, and independent sample 
T-tests were used for statistical 
analyses in SPSS.
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Methods
 •  Demographics
  –  Age: 45.1 ± 17.1 years
    •  Younger than general TIPS1
  –  54.8% female
•  Mortality: 6.3% overall
  –  Lower than general TIPS1,2
Results
 •  Demographics with higher odds 
of mortality include age > 70 
years old, male, Asian and Pacific 
Islander, and Medicare & self-pay.
•  Teaching hospitals had a lower 
odds of mortality.
•  Transfers from acute care 
hospitals had a higher mortality 
and cost.
•  Though liver transplant is 
ultimately the cure for BCS3, 
patients continue to have poor 
outcomes from complications at a 
high cost.
 •  Overall, there is a significantly lower inpatient mortality for TIPS 
in BCS patients when compared 
to general TIPS procedures (high 
value).
•  Both inpatient mortality and 
cost have increased over time, 
decreasing the value of TIPS for 
BCS patients; special precaution 
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•  In 2009, the American 
Association for the Study of Liver 
Diseases deemed Budd-Chiari 
Syndrome (BCS) an indication 
for Transjugular Intrahepatic 
Portosystemic Shunt (TIPS) 
procedures.
•  Studies on BCS patients who 
have undergone TIPS have been 
limited by sample size due to a 
low incidence of 0.13 - 0.36 per 
million.
•  Our study seeks to better 
understand the value of TIPS 
procedures provided to BCS 
patients. Table 1. Top 3 Diagnoses and Comorbidities with the Highest Odds      
of Inpatient Mortality 




Acute necrosis of liver (570) 12.261 <0.0005
Complications of transplanted liver (Begin 1987) (996.82) 5.700 0.003




Drug abuse 16.912 <0.0005
Peripheral vascular disorder 16.001 <0.0005
Coagulopathy 7.443 <0.0005
Table 2. Top 3 Diagnoses and Comorbidities with the Highest Costs.
Category Factor Cost Increase ($) P-value
Dx (Reference: 
BCS) ANOVA p 
<0.0005
 
Complications of transplanted liver (Begin 1987) ( 996.82) $120,456 <0.0005
TB of limb bones - unspec (0.15.50) $104,866 0.005




Peripheral vascular disorders $175,507 <0.0005
Pulmonary circulation disorders $141,543 <0.0005







































Total charges adjusted 
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Figure 1. Inpatient mortality had a slightly positive trend (m=0.0087) with a 
poor fit (R2 = 0.2308), with a peak of 15.3% in 2009.
Figure 2. Inpatient costs and charges increased over time. 
•  Cost: ~$4.5 million annually
  –  Mean: $75,039 + $93,579
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